Aptevo Therapeutics Inc (APVO) - Financial and Strategic SWOT Analysis Review

April 2021 | 48 pages | ID: A5EEBF98F1DEN
GlobalData

Abstracts

Aptevo Therapeutics Inc (APVO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Aptevo Therapeutics Inc (Aptevo) is a biotechnology company that develops and commercializes oncology and hematology therapeutics. Its pipeline products include APVO436 for the treatment of myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML); ALG.APV-527 for potential treatment of a broad spectrum of cancers including mesothelioma, cervical, prostate, renal, breast, non-small-cell-lung, gastric, colorectal and bladder cancers; APVO603 for solid tumors. The company has received Orphan Drug Designation (ODD) for its pipeline product APVO436 from the US FDA for the treatment of acute myelogenous leukemia (AML). The pipeline immuno-oncology candidates are built on its proprietary Adaptir platform technology. Aptevo is headquartered in Seattle, Washington, the US.

Aptevo Therapeutics Inc Key Recent Developments

Mar 31,2021: Aptevo Therapeutics reports 2020 financial results and provides business update
Nov 10,2020: Aptevo Therapeutics reports third quarter financial results and provides business update
Aug 14,2020: Aptevo Therapeutics reports second quarter 2020 financial results
May 13,2020: Aptevo Therapeutics reports first quarter 2020 financial results
Mar 25,2020: Aptevo Therapeutics reports 2019 financial results and provides business update

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

Aptevo Therapeutics Inc - Key Facts
Aptevo Therapeutics Inc - Key Employees
Aptevo Therapeutics Inc - Key Employee Biographies
Aptevo Therapeutics Inc - Major Products and Services
Aptevo Therapeutics Inc - History
Aptevo Therapeutics Inc - Company Statement
Aptevo Therapeutics Inc - Locations And Subsidiaries
Head Office

SECTION 2 – COMPANY ANALYSIS

Company Overview
Aptevo Therapeutics Inc - Business Description
R&D Overview
Aptevo Therapeutics Inc - Corporate Strategy
Aptevo Therapeutics Inc - SWOT Analysis
SWOT Analysis - Overview
Aptevo Therapeutics Inc - Strengths
Aptevo Therapeutics Inc - Weaknesses
Aptevo Therapeutics Inc - Opportunities
Aptevo Therapeutics Inc - Threats
Aptevo Therapeutics Inc - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Aptevo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Aptevo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Aptevo Therapeutics Inc, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Mar 31, 2021: Aptevo Therapeutics reports 2020 financial results and provides business update
Nov 10, 2020: Aptevo Therapeutics reports third quarter financial results and provides business update
Aug 14, 2020: Aptevo Therapeutics reports second quarter 2020 financial results
May 13, 2020: Aptevo Therapeutics reports first quarter 2020 financial results
Mar 25, 2020: Aptevo Therapeutics reports 2019 financial results and provides business update

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Aptevo Therapeutics Inc, Key Facts
Aptevo Therapeutics Inc, Key Employees
Aptevo Therapeutics Inc, Key Employee Biographies
Aptevo Therapeutics Inc, Major Products and Services
Aptevo Therapeutics Inc, History
Aptevo Therapeutics Inc, Key Competitors
Aptevo Therapeutics Inc, Ratios based on current share price
Aptevo Therapeutics Inc, Annual Ratios
Aptevo Therapeutics Inc, Annual Ratios (Cont...1)
Aptevo Therapeutics Inc, Interim Ratios
Aptevo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Aptevo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Aptevo Therapeutics Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

Aptevo Therapeutics Inc, Performance Chart (2016 - 2020)
Aptevo Therapeutics Inc, Ratio Charts
Aptevo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Aptevo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021